Stoffel EM, Brand RE, Goggins M (2023) Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology 164(5):752–765

Article  PubMed  Google Scholar 

Kenner BJ, Chari ST, Maitra A, Srivastava S, Cleeter DF, Go VL et al (2016) Early detection of pancreatic cancer-a defined future using lessons from other cancers: a white paper. Pancreas 45(8):1073–1079

Article  PubMed  PubMed Central  Google Scholar 

Rawla P, Sunkara T, Gaduputi V (2019) Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 10(1):10–27

Article  PubMed  PubMed Central  Google Scholar 

Werner J, Combs SE, Springfeld C, Hartwig W, Hackert T, Büchler MW (2013) Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol 10(6):323–333

Article  CAS  PubMed  Google Scholar 

Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7(3):163–172

Article  CAS  PubMed  Google Scholar 

Cancer Stat Facts: Pancreatic Cancer National Cancer Institute (2023). https://seer.cancer.gov/statfacts/html/pancreas.html

The Lancet Gastroenterology H (2019) Pancreatic cancer screening: more harms than benefits? Lancet Gastroenterol Hepatol 4(4):255

Klatte DCF, Onnekink AM, Hinnen C, van Doorn R, Potjer TP, van Leerdam ME et al (2023) Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: a focus group study. J Genet Couns. https://doi.org/10.1002/jgc4.1820

Article  PubMed  Google Scholar 

Goggins M, Overbeek KA, Brand R, Syngal S, Del Chiaro M, Bartsch DK et al (2020) Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 69(1):7–17

Article  CAS  PubMed  Google Scholar 

Sawhney MS, Calderwood AH, Thosani NC, Rebbeck TR, Wani S, Canto MI et al (2022) ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations. Gastrointest Endosc 95(5):817–826

Article  PubMed  Google Scholar 

Gabriele C, Salvatore P, Silvia C, Giovanni B, Erica S, Luca F et al (2020) Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group. Dig Liver Dis 52(10):1126–1130

Article  Google Scholar 

Aslanian HR, Lee JH, Canto MI (2020) AGA Clinical practice update on pancreas cancer screening in high-risk individuals: expert review. Gastroenterology 159(1):358–362

Article  CAS  PubMed  Google Scholar 

Levink IJM, Visser IJ, Koopmann BDM, van Driel LMJW, Poley JW, Cahen DL et al (2022) Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer. Gastrointest Endosc 96(5):801–13.e2

Article  PubMed  Google Scholar 

Ohmoto A, Yachida S, Morizane C (2019) Genomic features and clinical management of patients with hereditary pancreatic cancer syndromes and familial pancreatic cancer. Int J Mol Sci 20(3):561

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I et al (2013) International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut 62(3):339–347

Article  PubMed  Google Scholar 

Klatte DCF, Wallace MB, Löhr M, Bruno MJ, van Leerdam ME (2022) Hereditary pancreatic cancer. Best Pract Res Clin Gastroenterol 58–59:101783

Article  PubMed  Google Scholar 

Ulanja MB, Moody AE, Beutler BD, Antwi-Amoabeng D, Rahman GA, Alese OB (2022) Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival. Oncotarget 13:828–841

Article  PubMed  PubMed Central  Google Scholar 

Tsang ES, Topham JT, Karasinska JM, Lee MKC, Williamson LM, Mendis S et al (2021) Delving into early-onset pancreatic ductal adenocarcinoma: how does age fit in? Clin Cancer Res 27(1):246–254

Article  CAS  PubMed  Google Scholar 

Ginsburg GS, Wu RR, Orlando LA (2019) Family health history: underused for actionable risk assessment. Lancet 394(10198):596–603

Article  PubMed  PubMed Central  Google Scholar 

Shah I, Silva-Santisteban A, Germansky KA, Kandasamy C, Mlabasati J, Huang DC et al (2022) Association between family history and risk of pancreatic cancer in patients with BRCA1 and BRCA2 pathogenic variants. Pancreas 51(7):733–738

Article  CAS  PubMed  Google Scholar 

Roch AM, Schneider J, Carr RA, Lancaster WP, House MG, Zyromski NJ et al (2019) Are BRCA1 and BRCA2 gene mutation patients underscreened for pancreatic adenocarcinoma? J Surg Oncol 119(6):777–783

Article  CAS  PubMed  Google Scholar 

Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ et al (2004) Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 64(7):2634–2638

Article  CAS  PubMed  Google Scholar 

Shin DW, Kim J (2020) The American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma: is it better than the 7th edition? Hepatobiliary Surg Nutr 9(1):98–100

Article  PubMed  PubMed Central  Google Scholar 

Brosens LA, Hackeng WM, Offerhaus GJ, Hruban RH, Wood LD (2015) Pancreatic adenocarcinoma pathology: changing “landscape.” J Gastrointest Oncol 6(4):358–374

PubMed  PubMed Central  Google Scholar 

Cornish TC, Hruban RH (2011) Pancreatic intraepithelial neoplasia. Surg Pathol Clin 4(2):523–535

Article  PubMed  Google Scholar 

Longnecker DS, Suriawinata AA (2022) Incidence of pancreatic intraepithelial neoplasia in an autopsy series. Pancreas 51(4):305–309

Article  CAS  PubMed  Google Scholar 

Peters MLB, Eckel A, Mueller PP, Tramontano AC, Weaver DT, Lietz A et al (2018) Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: results of a simulation model. Pancreatology 18(8):928–934

Article  PubMed  Google Scholar 

Kiemen A, Braxton AM, Grahn MP, Han KS, Babu JM, Reichel R, et al. In situ characterization of the 3D microanatomy of the pancreas and pancreatic cancer at single cell resolution. bioRxiv. 2020:2020.12.08.416909

Weissman S, Thaker R, Zeffren N, Sarfaraz R, Dedousis J (2019) Intraductal papillary mucinous neoplasm of the pancreas: understanding the basics and beyond. Cureus 11(1):e3867

PubMed  PubMed Central  Google Scholar 

Bartsch DK, Matthäi E, Mintziras I, Bauer C, Figiel J, Sina-Boemers M et al (2021) The German National Case Collection for Familial Pancreatic Carcinoma (FaPaCa)—knowledge gained in 20 years. Dtsch Arztebl Int 118(10):163–168

PubMed  Google Scholar 

Bar-Mashiah A, Aronson A, Naparst M, DiMaio CJ, Lucas AL (2020) Elevated hemoglobin A1c is associated with the presence of pancreatic cysts in a high-risk pancreatic surveillance program. BMC Gastroenterol 20(1):161

Article  CAS  PubMed  PubMed Central  Google Scholar 

McNamara GPJ, Ali KN, Vyas S, Huynh T, Nyland M, Almanza D et al (2019) Characteristics and clinical outcomes of individuals at high risk for pancreatic cancer: a descriptive analysis from a comprehensive cancer center. Gastrointest Disord (Basel) 1(1):106–119

Article  PubMed  Google Scholar 

Paiella S, Capurso G, Cavestro GM, Butturini G, Pezzilli R, Salvia R et al (2019) Results of first-round of surveillance in individuals at high-risk of pancreatic cancer from the AISP (Italian Association for the Study of the Pancreas) Registry. Am J Gastroenterol 114(4):665–670

Article  PubMed  Google Scholar 

Sheel ARG, Harrison S, Sarantitis I, Nicholson JA, Hanna T, Grocock C et al (2019) Identification of cystic lesions by secondary screening of Familial Pancreatic Cancer (FPC) kindreds is not associated with the stratified risk of cancer. Am J Gastroenterol 114(1):155–164

Article  CAS  PubMed  Google Scholar 

Barnes CA, Krzywda E, Lahiff S, McDowell D, Christians KK, Knechtges P et al (2018) Development of a high risk pancreatic screening clinic using 3.0 T MRI. Fam Cancer 17(1):101–111

Article  PubMed  Google Scholar 

DaVee T, Coronel E, Papafragkakis C, Thaiudom S, Lanke G, Chakinala RC et al (2018) Pancreatic cancer screening in high-risk individuals with germline genetic mutations. Gastrointest Endosc 87(6):1443–1450

Article  PubMed  Google Scholar 

Lachter J, Rosenberg C, Hananiya T, Khamaysi I, Klein A, Yassin K et al (2018) Screening to detect precursor lesions of pancreatic adenocarcinoma in high-risk individuals: a single-center experience. Rambam Maimonides Med J 9(4):e0029

Article  PubMed  PubMed Central  Google Scholar 

Giulia Z, Marianna S, Stefano C, Massimo F, Paolo Giorgio A, Gabriele C (2019) Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals. Pancreatology 19(1):2–9

Article  Google Scholar 

Kimura W, Nagai H, Kuroda A, Muto T, Esaki Y (1995) Analysis of small cystic lesions of the pancreas. Int J Pancreatol 18(3):197–206

Article  CAS  PubMed  Google Scholar 

Kasper AO, Brechtje DMK, Iris JML, Matteo T, Nicole SE, Paolo Giorgio A et al (2024) Intraductal papillary mucinous neoplasms in high-risk individuals: incidence, growth rate, and malignancy risk. Clin Gastroenterol Hepatol 22(1):62-71.e7

Article